GeneDx Holdings Corp. Finance Lease, Principal Payments
GeneDx Holdings Corp. (WGS) reported Finance Lease, Principal Payments of $984.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Financing Activities
us-gaap:FinanceLeasePrincipalPayments · last filed 2026-08-03
- GeneDx Holdings Corp. finance lease, principal payments for the quarter ending 2026-06-30 was $489.00K, a 11.25% decline year-over-year.
- GeneDx Holdings Corp. finance lease, principal payments for the quarter ending 2026-03-31 was $495.00K, a 18.99% decline year-over-year.
- GeneDx Holdings Corp. finance lease, principal payments for the quarter ending 2025-12-31 was $377.00K, a 69.32% decline year-over-year.
- GeneDx Holdings Corp. finance lease, principal payments for the quarter ending 2025-09-30 was $912.00K, a 79.17% increase year-over-year.
- GeneDx Holdings Corp. finance lease, principal payments for fiscal 2025 was $2.45M, a 10.15% decline from fiscal 2024.
- GeneDx Holdings Corp. finance lease, principal payments for fiscal 2024 was $2.73M, a 24.18% decline from fiscal 2023.
- GeneDx Holdings Corp. finance lease, principal payments for fiscal 2023 was $3.60M, a 9.30% increase from fiscal 2022.
- GeneDx Holdings Corp. finance lease, principal payments for fiscal 2022 was $3.29M, a 11.70% decline from fiscal 2021.
| Period end | Finance Lease, Principal Payments 3 month | Finance Lease, Principal Payments 3 month as first filed | Finance Lease, Principal Payments 6 month | Finance Lease, Principal Payments 6 month as first filed | Finance Lease, Principal Payments 9 month | Finance Lease, Principal Payments 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $489.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $984.00K 10-Q · filed 2026-08-03 | $1.36M derived: sum of 3 quarters · filed 2026-08-03 | $2.27M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2026-03-31 | $495.00K 10-Q · filed 2026-05-04 | $872.00K derived: sum of 2 quarters · filed 2026-05-04 | $1.78M derived: sum of 3 quarters · filed 2026-05-04 | $2.33M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-12-31 | $377.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $1.29M derived: sum of 2 quarters · filed 2026-02-23 | $1.84M derived: sum of 3 quarters · filed 2026-08-03 | $2.45M 10-K · filed 2026-02-23 | ||
| 2025-09-30 | $912.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $1.46M derived: sum of 2 quarters · filed 2026-08-03 | $2.07M 10-Q · filed 2025-10-28 | $3.30M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-06-30 | $551.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $1.16M 10-Q · filed 2026-08-03 | $2.39M derived: sum of 3 quarters · filed 2026-08-03 | $2.90M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-03-31 | $611.00K 10-Q · filed 2026-05-04 | $1.84M derived: sum of 2 quarters · filed 2026-05-04 | $2.35M derived: sum of 3 quarters · filed 2026-05-04 | $2.88M derived: sum of 4 quarters · filed 2026-05-04 | ||
| 2024-12-31 | $1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $1.74M derived: sum of 2 quarters · filed 2026-02-23 | $2.27M derived: sum of 3 quarters · filed 2026-02-23 | $2.73M 10-K · filed 2026-02-23 | ||
| 2024-09-30 | $509.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $1.04M derived: sum of 2 quarters · filed 2025-10-28 | $1.50M 10-Q · filed 2025-10-28 | $2.96M derived: sum of 4 quarters · filed 2026-02-23 | ||
| 2024-06-30 | $528.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $990.00K 10-Q · filed 2025-07-29 | $2.46M derived: sum of 3 quarters · filed 2026-02-23 | $3.37M derived: sum of 4 quarters · filed 2026-02-23 | ||
| 2024-03-31 | $462.00K 10-Q · filed 2025-04-30 | $1.93M derived: sum of 2 quarters · filed 2026-02-23 | $2.84M derived: sum of 3 quarters · filed 2026-02-23 | $3.01M derived: sum of 4 quarters · filed 2026-02-23 | ||
| 2023-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $2.38M derived: sum of 2 quarters · filed 2026-02-23 | $2.55M derived: sum of 3 quarters · filed 2026-02-23 | $3.60M 10-K · filed 2026-02-23 | ||
| 2023-09-30 | $911.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $1.09M derived: sum of 2 quarters · filed 2024-10-29 | $2.13M 10-Q · filed 2024-10-29 | $2.79M derived: sum of 4 quarters · filed 2024-10-29 | ||
| 2023-06-30 | $175.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $1.22M 10-Q · filed 2024-07-30 | $784.00K 10-Q · filed 2023-08-08 | $1.88M derived: sum of 3 quarters · filed 2024-07-30 | $2.88M derived: sum of 4 quarters · filed 2024-07-30 | |
| 2023-03-31 | $1.05M 10-Q · filed 2024-04-29 | $609.00K 10-Q · filed 2023-05-09 | $1.71M derived: sum of 2 quarters · filed 2024-04-29 | $2.71M derived: sum of 3 quarters · filed 2024-04-29 | $3.48M derived: sum of 4 quarters · filed 2024-04-29 | |
| 2022-12-31 | $660.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $1.66M derived: sum of 2 quarters · filed 2024-02-23 | $2.43M derived: sum of 3 quarters · filed 2024-02-23 | $3.29M 10-K · filed 2024-02-23 | ||
| 2022-09-30 | $998.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $1.77M derived: sum of 2 quarters · filed 2023-11-03 | $2.63M 10-Q · filed 2023-11-03 | $3.40M derived: sum of 4 quarters · filed 2023-11-03 | ||
| 2022-06-30 | $772.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $1.63M 10-Q · filed 2023-08-08 | $2.40M derived: sum of 3 quarters · filed 2023-08-08 | $3.37M derived: sum of 4 quarters · filed 2023-08-08 | ||
| 2022-03-31 | $862.00K 10-Q · filed 2023-05-09 | $1.63M derived: sum of 2 quarters · filed 2023-05-09 | $2.60M derived: sum of 3 quarters · filed 2023-05-09 | |||
| 2021-12-31 | $768.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $1.73M derived: sum of 2 quarters · filed 2023-03-16 | $3.73M 10-K · filed 2023-03-16 | |||
| 2021-09-30 | $966.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $2.96M 10-Q · filed 2022-11-14 | ||||
| 2021-06-30 | $1.99M 10-Q · filed 2022-08-15 | |||||
| 2020-12-31 | $626.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $4.01M 10-K · filed 2023-03-16 | ||||
| 2020-09-30 | $3.38M 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |